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1. Introduction 
Colorectal cancer (CRC) is one of the most common tumors in our society. It is the most 
common gastrointestinal tumor and it is also estimated that between 5 and 6% of the 
population will suffer this tumor along their lives. Colorectal cancer is a tumor in which it is 
possible to perform primary and secondary prevention. It ranks second in frequency in both 
men and women, and it represents the second leading cause of cancer-related deaths in both 
men (after lung cancer) and women (after breast cancer). Indeed, CRC is responsible for 12% 
of cancer-related deaths in men and for 15% in women. It represents, therefore, a public 
health problem of first magnitude, causing over 10,500 annual deaths in Spain; so it is well 
established and cost effectiveness to use a program for early detection and prevention of this 
disease. CRC mortality in 2006 was almost double that the one recorded in Spain in 1975 in 
both sexes, considering them separately, and in the entire population as a whole. In relation 
to the rest of the Europe, Spain has an intermediate CRC mortality, lower than that recorded 
in Czech Republic or Slovakia, and well above from CRC mortality in Finland or Cyprus. In 
Spain, cancer mortality is higher in the north than in the south, and this difference is more 
significant in males. Furthermore, cancer mortality in the whole country is quite stable since 
the beginning of this century, observing a slight increase in northern regions. 
The survival of patients diagnosed with CRC is approximately 54% at 5 years after 
diagnosis. However, survival is significantly lower in the group of patients in advanced 
stages, and much higher, with a survival rate around 90%, when it comes to patients in early 
stages. Therefore, an early diagnosis of colorectal cancer can lead to a significant reduction 
in cancer mortality. Consequently, a program of screening or early detection could 
considerably improve the prognosis of this disease. 
Colorectal cancer is a health problem that fulfills all the requirements that the World Health 
Organization requires to consider a cost-effective screening program for early detection of 
neoplasia: first it is a very common disease, representing a major public health problem; 
second it is a disease with a well-known natural history, fulfilling in most cases the 
adenoma-carcinoma sequence (Figure 1), and this natural history is long enough so it can be 
interrupted by various diagnostic and therapeutic strategies; thirdly, we have diagnostic 
methods with enough diagnostic accuracy and at reasonable cost; fourthly, there is an 
effective treatment and, finally, this approach seems to be cost-effective. However, these 
screening programs have been implemented in very few sites in the world, having to be 
reduced in many cases to opportunistic screening or, at best, reduced to population at 
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highest risk of developing the disease, such as those suffering from predisposing diseases 
such as ulcerative colitis, or individuals with high familial risk of developing the disease. 
There is little doubt about the beneficial of a program for early detection of colon cancer: the 
diagnosis of the disease in an early stage practically ensures its cure, and even in many 
cases, we will be able to diagnose precancerous lesions and removing them we can avoid the 
appearance of cancer. The best prevention strategy is subject of discussion, especially in 
lower-risk patients. 
As expected, before proposing an individual for inclusion in a screening program it is essential 
to establish their individual risk of developing colon cancer. Routinely, the population is 
divided into three groups according to their risk of developing colorectal cancer (CRC): 
- Low-risk population: includes individuals younger than 50 years, without personal or 
family risk factors for developing CRC. In this population is not recommended CRC 
screening. 
- Average-risk population: they are people whose only risk factor for the condition of the 
disease is having an age over 50 years. Given the high incidence of the disease after this 
age, it is justified to perform an early diagnosis. 
- High-risk population: includes all individuals with personal risk factors (history of 
polyps or colorectal cancer or predisposing conditions such as inflammatory bowel 
disease) or family risk factors for cancer development. It is well known that the 
existence of first-degree relatives of colon cancer increases the risk for the disease; in 
addition, there are familial forms of cancer or hereditary syndromes (familial 
adenomatous polyposis and hereditary non-polyposis colorectal cancer are the most 
common).  
 
 
Fig. 1. Adenoma-carcinoma sequence represents the evolution of most colorectal 
carcinomas, from a normal colon to the development of an invasive carcinoma 
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2. The role of colonoscopy in preventing colorectal cancer 
Colonoscopy plays a dual role in preventing colorectal cancer. First, endoscopic examination 
of the colon and rectum is the gold standard in the diagnosis of neoplastic and preneoplastic 
lesions in the large intestine. On the other hand, the development of therapeutic techniques 
such as polypectomy or more complex techniques like endoscopic mucosal resection or 
endoscopic submucosal dissection, allows the removal of some of these lesions. Indeed, 
endoscopic resection is curative in almost all preneoplastic lesions (benign lesions) and may 
be curative in early malignant lesions, which are those that only affect the mucosa and 
submucosa. 
Colonoscopy is useful for the diagnosis of cancer and precancerous lesions. Unquestionably, 
despite radiological techniques are useful for diagnosis, the role of colonoscopy is essential 
firstly to confirm the radiological findings and also to obtain biopsy specimens for 
histological diagnosis. Colorectal cancer is frequently presented as proliferative lesions that 
produce some stenosis of the intestinal lumen, with ulcerated surface and even with 
hemorrhagic necrotic areas (Figure 2); sometimes they are polypoid lesions that can also 
have ulcerated areas (Figure 3), or just be circumscribed ulcerations (Figure 4). 
 
 
Fig. 2. Malignant lesion covering the entire circumference that produces stenosis of the 
intestinal lumen, with ulcerated surface, hemorrhagic necrotic areas and bleeding easily at 
the touch of endoscope 
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Fig. 3. Sessile polyp, with wide-based attachment, embossed surface, with ulcerated areas and a 
friable mucosa. Biopsies from the lesion suggest adenocarcinoma arising in a villous adenoma 
 
 
Fig. 4. Ulcer that affects 2 /  5 parts of the circumference of intestinal lumen, with raised and 
indurated edges. Biopsies suggested undifferentiated adenocarcinoma 
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Fig. 5. The picture shows two large pedunculated polyps. Adenomatous tissue is easily 
differentiated from the pedicle, consisting of normal mucosa, non-neoplastic 
 
 
Fig. 6. Sessile polyp, with wide-based attachment, in which it does not recognize any pedicle 
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The diagnosis of polyps is also quite distinctive, as outgrowths on the colonic mucosa with 
variable size and morphology. They can present as pedunculated lesions (Figure 5), sessile 
lesions (Figure 6), or as flat or very slightly raised lesions (Figure 7). Occasionally, lesions 
can be almost undetectable during a conventional colonoscopy, so some special techniques 
such as chromoendoscopy or modern techniques of Narrow Band Imaging and Computed 
Virtual Chromoendoscopy can be helpful to identify and study the lesions more accurately 
(Figure 8). After these lesions have been located and characterized, we should think in the 
possibility to perform the resection of the lesion by polypectomy (Figure 9) or endoscopic 
mucosal resection (Figure 10). 
Although, in general, the role of colonoscopy in preventing CRC can be summarized in the 
above, there are some differences in the groups of patients that have been differentiated 
according to their risk of developing the disease. For this reason, then we will discuss in 
greater detail, the place of colonoscopy in the screening strategies proposed for each of these 
patients. 
 
 
Fig. 7. Flat polyp, located in right colon close to the ileocecal valve. The lesion has a 
thickness of a few millimeters and a granular surface 
2.1 Usefulness of colonoscopy in preventing CRC in average risk population 
This is the largest group of individuals who would be subsidiaries of CRC prevention 
programs, so the group would consume a greater amount of resources. In fact, most 
colorectal carcinomas are sporadic, appearing in patients who have neither family history of 
disease or conditions predisposing to disease. 
The prevention strategy that arises in this population is, once assumed the failure of primary 
prevention, it takes place secondary prevention. That is, it is an early diagnosis of cancer or 
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Fig. 8. Laterally spreading tumor with granular surface, with sharply demarcated edges 
after performing vital staining with indigo carmine 2% 
 
 
Fig. 9. Endoscopic polypectomy by polypectomy snare of a pedunculated lesion of about 7 
mm in diameter, located in proximal transverse colon. The pathological study revealed the 
presence of a tubular adenoma with low grade dysplasia 
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precancerous lesions, in order to ensure a treatment with the best outlook for cure. In the 
case of diagnosis of polyps, colonoscopy and polypectomy allow the resection of the lesions 
and, thus, to prevent the occurrence of CRC. 
In this group the screening strategies accepted and recommended by different international 
and Spanish scientific societies are: 
- Fecal occult blood, immune test preferably (FOBT), on an annual or biennial periodicity. 
- Barium enema, replaced in most developed countries by the CT-colonography, every 5 
years. 
- flexible sigmoidoscopy every 5 years 
- total colonoscopy, every 10 years  
No comparative studies are available that allow us to establish which is the most cost 
effective strategy. Taking into account that the most questionable option is represented by 
radiological tests, it seems that the discussion focuses on the choice of test FOBT or 
colonoscopy. If we accept the numbers described in several studies, stating that, in patients 
at average risk, adenomas should be detected in at least 25% of screening colonoscopies, 
there are doubts about the profitability of the radiological techniques. However, at present, 
we do not have enough scientific evidence to choose any strategy, although there is an 
American study which points in this direction. In Spain it is estimated that the cost per year 
of life saved using immunological fecal occult blood annually is around € 1,200, and it is € 
2,300 for sigmoidoscopy every 5 years or colonoscopy every ten years. Both cases demonstrate 
the low cost of these screening programs when we compared them with other established 
screening systems for other malignancies such as cervical or breast cancer, whose cost is 
approximately 5-6 times higher.  
The screening of colorrectal cancer in average risk population implies a significant increase 
in the number of colonoscopies that we must perform in our units. There are some concers 
about this situation. Perharps, there are no enough endoscopists in our health system to 
answer this raising demand of colonoscopies. The spanish health system should consider 
this limitations before the implementation of a screening program. 
2.2 Prevention of colorrectal cancer in patients with personal history of polypectomy 
or CRC 
Patients in which colonic polyps were removed or that have been treated for colon cancer 
should be included in specific monitoring systems. So this is tertiary prevention, and the 
aim is to detect metachronous lesions that appear in the months or years after the onset of 
the initial lesion. This disclosure is based on the possibility that the patient could have 
synchronic small lesions that could have not been detected in the initial colonoscopy. When 
performing a new examination in a reasonable period of time, these lesions would be 
detected in early stages yet. On the other hand, it is also known that these patients have an 
increased risk of presenting new lesions in the future. The only test accepted by all societies 
for these patients is colonoscopy. 
The frequency of follow-up colonoscopies will be determined by the type of lesions 
presented by the patients. Naturally, any recommendation is based on the fundamental 
principle that colonoscopies performed meet all the standards of quality: good bowel 
preparation, full colon examination and mean colonoscopic withdrawal times of at least 6 
minutes. In fact, all the factors mentioned above, especially the last one, are significantly 
correlated with the rate of polyps detected at screening colonoscopy. 
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Fig. 10. Picture showing endoscopic mucosal resection of a large flat polyp placed in rectum. 
The size of the polypectomy snare allows us to approximate the size of the lesion, which is 
about twice the size of it, so about 6 cms. The resection is performed gradually, in several 
fragments (piecemeal resection). By this way large lesions can be removed 
The number and characteristics of the resected polyps are, therefore, the key factors to 
establish the date of the next examination. The existence of multiple adenomas (more than 
three) or a polyp that has a size greater than 10 mm or, regardless of size, the polyp has a 
villous component or high grade dysplasia (advanced adenoma); leads to set the following 
colonoscopy within three to five years. If the number of adenomas removed is larger than 
10, we recommend surveillance colonoscopy within less than 3 years. When these conditions 
are not are satisfied (less than three adenomas, without advanced adenoma characteristics), 
the next examination should be done within five to ten years. In case of a first surveillance 
examination without evidence of new adenomas, subsequent colonoscopies should be 
performed every 5 years. 
In patients who have been treated for colorectal cancer, as well as in patients with 
adenomas, we should have a complete study of the colon before surgery or at least within 6 
months. In case of obstructive tumors in which it is impossible to complete a study by 
colonoscopy, we can complete the examination of the colon with a CT-colonography. Most 
clinical practice guidelines recommend a review of the surgical anastomosis within one year 
after the intervention, to rule out a possible anastomotic recurrence and then, the 
recommendations are the same as those for patients undergoing endoscopic polypectomy: 
the first examination after three years and the following ones, if not metachronous lesions 
were detected, should be performed at intervals of 5 years. In case of detecting lesions 
during follow-up, its features will condition the surveillance. 
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2.3 CRC screening in patients with inflammatory bowel disease 
People suffering from inflammatory bowel disease, especially ulcerative colitis have an 
increased risk of colon cancer. The risk is only increased in patients with extensive disease, 
thus it is not indicated endoscopic surveillance in patients with ulcerative colitis that only 
affects the rectosigmoid region. However there are a number of factors that are associated 
with a significant rise in the incidence of colon cancer. Indeed, the risk increases 
significantly if there are family history of colon cancer, if primary sclerosing cholangitis is 
associated with ulcerative colitis and, undoubtedly, if it is a disease with difficult control 
with persistent inflammation and presence of inflammatory pseudopolyps. Patients with 
Crohn's disease with extensive colonic involvement may also have an increased risk of 
developing colon cancer, so surveillance should also be extended to this group of patients. 
The risk increases significantly after 8-10 years of development, being that the moment in 
which it is recommended to start the monitoring programs. Naturally, and taking into 
consideration that what we are looking for is the presence of dysplasia, colonoscopy with 
biopsy of colorectal mucosa is the only valid screening strategy. However, the evidence 
supporting this colorectal cancer screening is poor. Several studies suggest that the inclusion 
of patients in screening programs improves the prognosis of the disease because many cases 
would be diagnosed in early stages. In contrast, other studies doubt about the utility of 
specific screening programs, since most malignancies would be diagnosed as interval cancers. 
Although scientific evidence is little and poor, the majority of international clinical practice 
guidelines, and also guidelines available in Spain, recommend to start with screening from 
8-10 years after development of the disease in extensive colitis, and from 15 years in colitis 
that just involve the left colon. As explained before, it is not justified to perform any kind of 
endoscopic screening in patients with only rectal involvement. Initially it would be 
recommended to perform colonoscopy every 2-3 years, and then to increase in frequency 
because the incidence of colon cancer increases with duration of disease. It has been 
suggested to perform colonoscopies every two years after 20 years since the diagnosis of the 
disease and annually after 30 years of development of ulcerative colitis. It is also included in 
most guidelines the recommendation to intensify surveillance in patients with sclerosing 
cholangitis due to its association with an increased risk of CRC, indicating to perform an 
annual colonoscopy at the time of diagnosis of primary sclerosing cholangitis. 
The best way to prevent the appearance of colon cancer is an early detection of dysplasia. 
Therefore, we should carefully explore all of the colon mucosa, trying to detect any mucosal 
lesion (minimum mucosal elevation, polyp, mass ...) and if so, we should take biopsies. 
Additionally, biopsies from the entire colonic mucosa should be systematically taken and 
the most widely recommendation accepted is taking 4 biopsy specimens every 10 cm of 
intestine. As expected, the examinations are hardworking and, with the available evidence, 
we can not ensure its cost effectiveness. In order to make these examinations less time-
consuming and possibly more cost effective, several studies propose to take biopsies in a 
targeted way, using magnification endoscopy and chromoendoscopy. Thus, these techniques 
help us to choose the areas that we need to biopsy, and this could probably improve the 
detection of dysplasia and also they can help us in reducing the number of biopsies that 
should be taken. At the present time confocal endomicroscopy is under study. This technique 
allows subsurface histological diagnosis in situ, without taking biopsies, and it could 
probably be more helpful detecting dysplasia. However, these are very long examinations, 
and this technique requires an expensive technology and a specialized training by the 
endoscopist, so it becomes a technique restricted to highly specialized centers. 
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There is some agreement on the way to approach after detecting dysplasia. Due to the high 
incidence of synchronous adenocarcinoma with high-grade dysplastic foci, it is usually 
recommended to perform a total proctocolectomy after detecting high-grade dysplasia. In 
case a low-grade dysplasia, the decision is more controversial. If multiple foci of dysplasia 
on flat mucosa are detected, it is recommended to perform a proctocolectomy. On the other 
hand, if isolated foci of dysplasia are detected the recommendation should be to perform a 
new colonoscopy within approximately 3-6 months. Subsequently, following colonoscopies 
should be performed every 6 months. 
Elevated lesions or masses can appear in patients with ulcerative colitis, and in many cases 
they are similar to adenomas. The presence of dysplasia on these raised lesions causes a 
difficult differential diagnosis with sporadic adenomas that are defined by the presence of 
dysplasia and whose treatment could be endoscopic polypectomy. Generally, we consider 
dysplasia-associated lesion or mass (DALM) if the lesion is located on “colitic”  mucosa 
(even in quiescent ulcerative colitis), while if it appears on normal mucosa, it is probably 
sporadic adenoma. Sporadic adenoma should be treated as in the general population and 
DALM could also be endoscopically removed after ruling out the presence of dysplastic 
lesions in the surrounding mucosa. If this is not technically possible or perilesional mucosal 
biopsies present dysplastic foci, we should perform a total colectomy. If we have performed 
endoscopic resection of the lesion, we should take biopsies of the mucosa around the lesion 
in 3-6 months, and also the following colonoscopies should be performed every six months. 
The work for pathologist is not always easy and he can find cases in which, mainly due to 
the persistence of inflammatory activity, the findings are not definitive to confirm or exclude 
dysplasia. In these cases, endoscopy should be repeated within 3-6 months after an 
appropriate control of mucosa inflammation under a specific treatment. 
As presented, colonoscopy is essential in monitoring these patients, being the only tool that 
allows taking biopsies to detect dysplasia. However, there is a long way to walk until we 
find the ideal strategy to make examinations less time-consuming and more cost effective. 
Everything suggests that modern endoscopic techniques (magnification endoscopy and 
chromoendoscopy) can be the key, but there is little scientific evidence by now. Secondly, 
the steps to follow in case of dysplasia seem to be more established. Finally, colonoscopy 
may have a therapeutic role if we detect low-grade dysplastic foci on lesions and masses 
similar to adenomas.  
2.4 Colorectal cancer screening strategies in patients with family history of CRC 
The risk of colorectal cancer is higher in those people who belong to families where cases of 
CRC have been recorded, even after having ruled out the possibility of polyposis syndromes 
and hereditary colorectal cancer. However, the risk depends on several factors: the number 
of relatives affected, the degree of kinship and age at which the neoplasm is detected. In 
second-degree relatives, excepting they were multiple family members affected, it is not 
justified any special CRC screening, and the recommendations are the same as for medium-
risk population. In case of multiple second-degree relatives affected, the different scientific 
societies recommend the same screening strategy as for people at average risk, but starting 
the screening program at age 40 years. In case of several first-degree relatives or a single 
family member younger than 60 years at the time of diagnosis, the only recommendation 
accepted is to perform colonoscopy every five years. The age to start the screening will be at 
40 years of age or at age 10 years younger than the youngest case diagnosed in the family. 
The presence of a single first-degree relative older than 60 years increases the risk of 
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developing the disease but in a lesser way, so the recommendations are the same as if there 
were second-degree relatives affected. 
In summary, if there is a family history of colorectal cancer, the risk is increased respecting to 
the average risk population. If there is a low risk family history, as well as medium-risk 
population, the acceptable screening tests include fecal occult blood testing, colonoscopy and 
radiological tests. By contrast, if there is a high risk family history the only accepted screening 
test is colonoscopy because there are higher possibilities of detecting cancer or polyps. 
2.5 Hereditary CRC syndromes: non-polyposis colorectal cancer and familial 
adenomatous polyposis  
2.5.1 Hereditary non-polyposis colorrectal cancer or Lynch syndrome 
Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome is an autosomal 
dominant disease which represents less than 2% of total CRC. It is mostly due to mutations 
in DNA repair genes and, clinically, it is characterized by the development of neoplasia in 
young people (under 50 years) with high preference for right colon, with great tendency to 
develop synchronous and metachronous neoplasms as well as in other organs (urinary tract, 
biliary tract, endometrium, pancreas, stomach, small intestine and ovary). It is more 
uncommon to find development of osteomas, skin or brain tumors. Pathologically it is 
characterized by a strong tendency to present a mucinous histology. 
The diagnosis is based on the Amsterdam criteria: at least three relatives affected, one of 
whom is a first degree relative of the other, at least two successive generations involved and 
at least one case diagnosed of cancer before age 50. Then, these criteria were found to be too 
strict and were expanded to include the associated non-colorectal cancers (Amsterdam II). In 
any case, these criteria have poor sensitivity for the diagnosis of the disease, although its 
specificity is very high. Therefore, the Bethesda criteria were established, suspecting the 
disease by demonstrating on the resected tumor the presence microsatellite instabilty 
(expression of mutations in repair genes). It is mandatory to perform a genetic analysis 
whether if diagnosis is based on the Amsterdam criteria or on the analysis of microsatellite 
instability. If the mutation responsible for the disease is detected in a patient, the family 
members should be studied, and only those who file such mutations will be subsidiary to 
perform the screening program. 
The aim of endoscopic surveillance of people belonging to families with Lynch syndrome is 
the early detection of cancer or polyps and their removal when it is possible. In many cases, 
precancerous lesions are flat lesions, and may not be detected by non-endoscopic 
techniques, so the only acceptable diagnostic technique for monitoring is the colonoscopy. 
Even these lesions are difficult to detect with conventional endoscopy, which may explain 
the high frequency of interval cancers. For this reason it was suggested to use more 
sophisticated endoscopic techniques (Narrow Band Imaging and chromoendoscopy) to 
facilitate the detection of these lesions. In our experience, chromoendoscopy seems to be 
easier to perform and to interpret. To do it, it is essential a correct colon cleansing and 
staining of the colonic mucosa with a solution of Indigo Carmine 0.2%. This will 
significantly improve the detection of flat lesions, almost imperceptible by conventional 
colonoscopy. The use of magnification endoscopy can further improve diagnostic accuracy. 
Computed virtual chromoendoscopy (CVC or FICE, Fujinon) (Figure 11) can be an 
alternative to conventional chromoendoscopy (Figure 12), avoiding the use of colorants and 
making even shorter examinations, but of course, it depends on the availability of this 
technology. The use of NBI (Figure 13) may be helpful for the characterization of lesions, but 
this technique may be more complicated than chromoendoscopy. 
www.intechopen.com
 The Role of Colonoscopy in the Prevention of Colon and Rectal Cancer   
 
207 
 
Fig. 11. Flat lesion in the right colon in a patient with quiescent ulcerative colitis, studied by 
CVC, Set 4 
The interval between examinations in these cases is determined by finding the adenoma-
dysplasia-carcinoma progression significantly shortened or even that it does not exist. It has 
been shown that performing examinations every 3 years had managed to reduce the 
incidence and the CRC mortality in more than 60%. However, widespread recommendations 
propose to perform colonoscopies every 1 or 2 years. Patients operated on for CRC in the 
context of Lynch syndrome have a high possibility of metachronous lesions, so post-resection 
surveillance recommendation is the same as the screening strategy for relatives at risk. The 
age at onset of endoscopic surveillance is usually established around 20-25 years of age or 10 
years younger than the youngest case in the family, choosing the option that happens before. 
In conclusion, in people from families with Lynch syndrome it is justified to perform 
surveillance programs. The only acceptable alternative is to conduct endoscopic surveillance 
and, based on current evidence, conventional endoscopy may not be sufficient. The use of 
chromoendoscopy and magnification endoscopy may be useful, so monitoring of these 
patients should be performed in specialized endoscopy units with endoscopists trained in 
these techniques. 
2.5.2 Familial adenomatous polyposis  
The classic form of familial adenomatous polyposis (FAP) is characterized by the 
development of hundreds of polyps in the colon, usually after puberty. Its pattern of 
inheritance is autosomal dominant and in the absence of surgical treatment, 100% of patients 
would develop cancer. An attenuated form of familial adenomatous polyposis has been 
identified. Individuals with attenuated FAP develop 20-100 adenomatous polyps and the 
average age of diagnosis is ten years later than in the classic form. There is the possibility of 
developing polyps at other gastrointestinal levels or tumors in other locations.  
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Fig. 12. Flat lesion, almost imperceptible to conventional endoscopy, which clearly demarcates 
with 0.2% indigo carmine. This is a patient who performed a colonoscopy as colorectal 
cancer screening method because he belonged to a family that fulfilled the Amsterdam 
criteria for diagnosing HNPCC. This is a lesion that, according to the Paris classification of 
superficial gastrointestinal neoplasia, can be a category IIc (excavated or depressed). 
According to its size (about 25 mm) endoscopic resection can not be considered. Indeed, the 
study of the surgical specimen showed the presence of adenocarcinoma with infiltration of 
the muscularis propria (pT2) 
The diagnosis is based on detection of polyps by endoscopy and histologic confirmation of 
the presence of adenomas. Then, genetic testing should be performed to identy APC gene 
mutations. However, mutations are not identified up to 30% of cases. Most diagnoses occur 
in relatives of patients affected, who are included on endoscopic surveillance programs. The 
recommended strategy in most guidelines is performing sigmoidoscopy every 1-2 years 
from 13-15 years of age and up to 40. From this age, they are recommended every 5 years 
until 60 years. In attenuated FAP, screening begins at age 10 years older than in classical 
FAP, and as polyps are more likely to appear on the right colon, colonoscopy should be 
complete. Also, chromoendoscopy may improve the detection rate of polyps on these 
patients. 
When individuals are diagnosed, prophylactic colectomy should be considered. The 
standard surgery is proctocolectomy with ileo-anal reservoir. In patients with reservoir, 
endoscopic examinations should be performed every 3 years. In patients who have 
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preserved the rectum (for example in attenuated FAP it is a good option, if there are few 
polyps in rectum), endoscopic examination should be performed every 6-12 months. 
 
 
Fig. 13. Flat lesion, about 10 mm, located in the hepatic flexure of colon, visualized with NBI. 
This is a IIa lesion according to the Paris classification. Endoscopic resection and histological 
study of it showed a villous adenoma with high grade dysplasia 
Due to these patients may have adenomas in other locations of the upper gastrointestinal 
tract, other endoscopic procedures should be performed. It is recommended to perform a 
gastroscopy every 4-5 years starting from age 25. If no adenomas are detected, another 
possibility is to take random biopsies on the duodenal folds. Additionally, it is recommended 
using side vision duodenoscope for further examination of the papillary area to detect 
ampulomas. Treatment of duodenal adenomas is controversial. Endoscopic resection of 
them seems to be not very effective, especially if they are many, and it is a technique that is 
not exempt of complications. The severity of the lesions is established by Spiegelman 
classification, which takes into account the number of adenomas, size, histological type and 
presence of dysplasia. In patients with duodenal adenomas Spiegelman stage I-II disease, 
endoscopic surveillance could be performed every 2-3 years, but in patients with more 
complex cases, monitoring should be stricter, like performing endoscopy every 6-12 months, 
but probably surgical treatment should be the best option in these cases. On the other hand, 
endoscopic removal of the most significant adenomas could delay surgical decision. 
There are some other forms of polyposis, like MYH-associated polyposis (MAP) which 
appears to be similar to other hereditary conditions as attenuated familial adenomatous 
polyposis, so screening strategies in people with MAP should be similar to screening in 
people with attenuated FAP.  
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3. Conclusions 
As we have explained, colonoscopy plays an important role in preventing colorectal 
carcinoma. In average risk populations for developing of cancer, it is one of the recommended 
screening strategies. In this population it has not yet been demonstrated which one is the 
most cost-effective strategy. What is unquestionable is the role of colonoscopy because of its 
therapeutic approach on the removal of lesions detected by other techniques or by its own. 
In high-risk populations, the only acceptable strategy is screening colonoscopy. The frequency 
of examinations is determined in each case by the particular risk of developing CRC. In 
some cases, such as patients with long-standing ulcerative colitis or individuals from families 
with Lynch syndrome, conventional colonoscopy is not enough, requiring using special 
techniques for endoscopic diagnosis, such as chromoendoscopy and magnification endoscopy. 
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